We were able to achieve a complete withdrawal of immunosuppression in some selected patients. Although the mechanism of graft acceptance in these patients has yet to be elucidated, we believe that a majority of long-term patients undergoing living donor liver transplantation may, thus, be potential candidates to be successfully weaned from immunosuppression.

Background Microscopic vascular invasion is an important risk factor for recurrent

BACKGROUND: Although the effect of synbiotic therapy using prebiotics

1Subcutaneous liver tissue engineering is an attractive and minimally invasive approach used 2 for curative treat hepatic failure and inherited liver diseases. However, graft failure occurs